DISCOVER PHARMASHELL®

CONTROLLED RELEASE, SMARTER CARE

Our advanced drug formulation technology PharmaShell® is enabling a new generation of Long-Acting Injectables to deliver more comfortable, convenient and tolerable long-term therapies in therapeutic areas from hematology and oncology to cardiovascular disorders, psychiatry and more.

Using Atomic Layer Deposition, PharmaShell®can precisely customize the API particles in injectables so that they release slowly and smoothly into the bloodstream with controlled precision over days, weeks or months – reducing costs, increasing compliance and ultimately enabling smarter care.

What is PHARMASHELL®?

Discover our advanced drug formulation technology PharmaShell®, and the unique Atomic Layer Deposition science that it employs.

READ MORE

What are the benefits?

A new formulation of Lenalidominde, a core drug in the treatment of MM (multiple myeloma), a rare cancer of plasma cells in the bone marrow.

READ MORE